Baxalta Incorporated (BXLT) Q2 Revenue Tops Views, Offers Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to Baxalta Incorporated (BXLT) Q2 Revenue Tops Views, Offers Outlook

Baxalta Incorporated (BXLT) Announces Expanded HYQVIA Coverage from CMS

August 3, 2015 8:36 AM EDT

Baxalta Incorporated (NYSE: BXLT) announced that the Centers for Medicare and Medicaid Services (CMS) have expanded coverage to include in-home use of HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase], a treatment for adults with primary immunodeficiency (PI).

PI is the name for a group of more than 200 diseases wherein part of the persons immune system is missing or not functioning correctly.1 People with PI may be more likely to get infections, take longer to recover from... More